🇺🇸 FDA
Pipeline program

KEYTRUDA 25 mg/mL concentrate for solution for infusion, PEMETREXED, CARBOPLATIN, KEYTRUDA 25 mg/mL concentrate for solution for infusion

SB27-3004

Phase 3 small_molecule active

Quick answer

KEYTRUDA 25 mg/mL concentrate for solution for infusion, PEMETREXED, CARBOPLATIN, KEYTRUDA 25 mg/mL concentrate for solution for infusion for Non-small Cell Lung Cancer is a Phase 3 program (small_molecule) at Samsung Bioepis NL B.V. with 1 ClinicalTrials.gov record(s).

Program details

Company
Samsung Bioepis NL B.V.
Indication
Non-small Cell Lung Cancer
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials